When was Jialin Pharmaceutical listed on the backdoor?

Jialin Pharmaceutical was listed on the backdoor as early as 20 16. Jialin Pharmaceutical 20 16 was listed in Tianshan Textile, and its core product A Le was the first atorvastatin generic drug in China. The annual sales of 20 16 is about1400 million yuan. As it is a low-opening model, according to the industry average discount rate of 30%, the terminal market size of the company in A Le is about 4.8 billion yuan, and the market share of statins is second only to that of Lipitor of Pfizer.